Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says [CNBC]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: CNBC
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S. The update raises the potential of the FDA to remove the blockbuster injections from its shortage list entirely, which could prevent compounding pharmacies from making customized and often cheaper versions of those branded drugs. All doses of Novo Nordisk 's highly popular weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the U.S. Food and Drug Administration's drug shortage database on Wednesday. It is a sign that Novo Nordisk's efforts to ramp up the supply of those weekly drugs are starting to pay off, as demand continues to skyrocket in the U.S. A previous update said the lowest dose of Wegovy — 25 milligrams — was still in short supply. Several doses of semaglutide, the active ingredient in Wegovy and Ozempic, have been on the FDA's shortage list since early 2022
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity [CNBC]CNBC
- Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds [MSNBC.com]MSNBC.com
- Lilly Cuts Guidance on Disappointing Weight-Loss Drug Sales [BNN Bloomberg (Canada)]BNN Bloomberg
- Lilly Cuts Guidance on Disappointing Weight-Loss Drug Sales [Yahoo! Finance Canada]Yahoo! Finance Canada
- Lilly Cuts Guidance on Disappointing Weight-Loss Drug Sales [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 8/8/24 - Beat
NVO
Sec Filings
- 10/28/24 - Form 6-K
- 10/21/24 - Form 6-K
- 10/21/24 - Form 6-K
- NVO's page on the SEC website